Annual Drug Patent Expirations for DEFITELIO
Defitelio is a drug marketed by Jazz Pharms Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has twenty-five patent family members in seventeen countries.
The generic ingredient in DEFITELIO is defibrotide sodium. One supplier is listed for this compound. Additional details are available on the defibrotide sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com